Search hospitals > Oregon > Bend
Saint Charles Health System
Claim this profileBend, Oregon 97701
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Stomach Cancer
Conducts research for Breast cancer
Conducts research for Relapse
294 reported clinical trials
8 medical researchers
Summary
Saint Charles Health System is a medical facility located in Bend, Oregon. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, Breast cancer, Relapse and other specialties. Saint Charles Health System is involved with conducting 294 clinical trials across 473 conditions. There are 8 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Expert in Skin Cancer
Studies Uterine Tumors
53 reported clinical trials
99 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Skin Cancer
Studies Relapse
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center5 years of reported clinical research
Expert in Skin Cancer
Studies Stomach Cancer
26 reported clinical trials
63 drugs studied
Clinical Trials running at Saint Charles Health System
Breast Cancer
Skin Cancer
Breast cancer
Bladder Cancer
Lung Cancer
Prostate Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Stomach Cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Charles Health System?
Saint Charles Health System is a medical facility located in Bend, Oregon. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, Breast cancer, Relapse and other specialties. Saint Charles Health System is involved with conducting 294 clinical trials across 473 conditions. There are 8 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.